Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/ recipient pairs matched at five HLA loci

Tissue Antigens

Volumn 63, Issue 4, 2004, Pages 362-368

  Li, S ^a   Kawata, H ^a   Katsuyama, Y ^b   Ota, M ^b   Morishima, Y ^c   Mano, S ^a   Kulski, J K ^a,d   Naruse, T ^a   Inoko, H ^a,e  

^a TOKAI UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d MURDOCH UNIVERSITY   (Australia)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Compatibility; Graft vs host disease; Hematopoietic stem cell transplantation; Human leukocyte antigen; Microsatellite markers; Polymorphism

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; GENETIC RISK; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY GENE; HLA MATCHING; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; POLYMORPHIC LOCUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC MARKERS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; LEUKEMIA; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PROGNOSIS; RECURRENCE;

MARTES PENNANTI;

EID: 1642482836     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00200.x     Document Type: Article

References (37)

1. Sasazuki T, Juji T, Morishima Y et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998: 339: 1177-85.
2. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993: 328: 593-602.
3. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998: 338: 962-8.
4. Morishima Y, Sasazuki T, Inoko H et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002: 99: 4200-6.
5. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, and DR identical unrelated donor marrow transplantation. Blood 1995: 86: 1606-13.
6. Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997: 89: 1818-23.
7. Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998: 92: 3515-20.
8. Grumet FC, Hiraki DD, Brown BWM et al. CD31 mismatching affects marrow transplantation outcome. Biol Blood Marrow Transplant 2001: 7: 503-12.
9. Ishikawa Y, Kashiwase K, Okai M et al. Polymorphisms in the coding region of mtDNA and effects on clinical outcome of unrelated bone marrow transplantation. Bone Marrow Transplant 2001: 28: 603-7.
10. Juji T, Watanabe Y, Ishikawa Y et al. Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation. Tissue Antigens 1999: 54: 229-34.
11. Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996: 334: 281-5.
12. Tseng LH, Lin MT, Hansen JA et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999: 15: 2911-4.
13. Gallardo D, Arostegui JI, Balas A et al. Disparity for the minor histocompatibility antigen HA-1 is associated with increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001: 114: 931-6.
14. Akatsuka Y, Nishida T, Kondo E et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med 2003: 197: 1489-500.
15. Kodera Y, Morishima Y, Kato S et al. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 1999: 24: 995-1003.
16. Shiina T, Tamiya G, Oka A et al. Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1,796,938-bp HLA class I region. Proc Natl Acad Sci USA 1999: 96: 13282-7.
17. Shiina T, Tamiya G, Oka A, Takishima N, Inoko H. Genome sequencing analysis of the 1.8 Mb entire human MHC class I region. Immunol Rev 1999: 167: 193-9.
18. Foissac A, Salhi M, Cambon-Thomsen A. Microsatellites in the HLA region: 1999 update. Tissue Antigens 2000: 55: 477-509.
19. Tamiya G, Ota M, Katsuyama Y et al. Twenty-six new polymorphic microsatellite markers around the HLA-B, -C and -E loci in the human MHC class I region. Tissue Antigens 1998: 51: 337-46.
20. Tamiya G, Shiina T, Oka A et al. New polymorphic microsatellite markers in the human MHC class I region. Tissue Antigens 1999: 54: 221-8.
21. Matsuzaka Y, Makino S, Inoko H et al. New polymorphic microsatellite markers in the human MHC class III region. Tissue Antigens 2001: 57: 397-404.
22. Cullen M, Malasky M, Harding A, Carrington M. High-density map of short tandem repeats across the human major histocompatibility complex. Immunogenetics 2003: 54: 900-10.
23. Oka A, Tamiya G, Inoko H et al. Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet 1999: 8: 2165-70.
24. Mizuki N, Ota M, Yabuki K et al. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 2000: 41: 3702-8.
25. Ota M, Katsuyama Y, Kimura A et al. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics 2001: 71: 263-70.
26. Keicho N, Ohashi J, Tamiya G et al. Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis. Am J Hum Genet 2000: 66: 501-7.
27. Matsuzaka Y, Makino S, Okamoto K et al. Susceptibility locus for non-obstructive azoospermia is localized within the HLA-DR/DQ subregion: primary role of DQB1*0604. Tissue Antigens 2002: 60: 396-9.
28. Oka A, Hayashi H, Tomizawa M et al. Localization of a non-melanoma skin cancer susceptibility region within the major histocompatibility complex by association analysis using microsatellite markers. Tissue Antigens 2003: 61: 203-10.
29. Carrington M, Wade J. Selection of transplant donors based on MHC microsatellite data. Hum Immunol 1996: 50: 151-4.
30. Moghaddam PH, Zwinderman A, Kazemi M et al. D6STNFa microsatellite locus correlates with CTLp frequency in unrelated bone marrow donor-recipient pairs. Hum Immunol 1998: 59: 295-301.
31. Gaudieri S, Kulski JK, Dawkins RL, Gojobori T. Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene 1999: 238: 157-61.
32. Foissac A, Fort M, Clayton J et al. Microsatellites in the HLA region: HLA prediction and strategies for bone marrow donor registries. Transplant Proc 2001: 33: 491-2.
33. Ratanatharathorn V, Ayash L, Lazarius HM et al. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001: 28: 121-9.
34. Schmaltz C, Alpdogan O, Muriglan SJ et al. Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 2003: 101: 2440-5.
35. Christiansen FT, Witt CS, Dawkins RL. Questions in marrow matching: the implications of ancestral haplotypes for routine practice. Bone Marrow Transplant 1991: 8: 83-6.
36. Witt C, Moghaddam HP, van der Meer R et al. Matching for TNF microsatellites is strongly associated with matching for other non-HLA MHC sequences in unrelated bone marrow donor-recipient pairs. Hum Immunol 1999: 60: 862-6.
37. Tay GK, Witt CS, Christiansen FT, Charron D et al. Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation. Bone Marrow Transplant 1995: 15: 381-5.